1. Home
  2. GAME vs GBIO Comparison

GAME vs GBIO Comparison

Compare GAME & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAME
  • GBIO
  • Stock Information
  • Founded
  • GAME 2011
  • GBIO 2016
  • Country
  • GAME United States
  • GBIO United States
  • Employees
  • GAME N/A
  • GBIO N/A
  • Industry
  • GAME
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • GAME
  • GBIO Health Care
  • Exchange
  • GAME Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • GAME 74.8M
  • GBIO 29.5M
  • IPO Year
  • GAME 2009
  • GBIO 2020
  • Fundamental
  • Price
  • GAME $0.95
  • GBIO $4.51
  • Analyst Decision
  • GAME Strong Buy
  • GBIO Strong Buy
  • Analyst Count
  • GAME 3
  • GBIO 4
  • Target Price
  • GAME $3.67
  • GBIO $73.33
  • AVG Volume (30 Days)
  • GAME 25.6M
  • GBIO 206.6K
  • Earning Date
  • GAME 08-13-2025
  • GBIO 08-06-2025
  • Dividend Yield
  • GAME N/A
  • GBIO N/A
  • EPS Growth
  • GAME N/A
  • GBIO N/A
  • EPS
  • GAME N/A
  • GBIO N/A
  • Revenue
  • GAME $99,579,536.00
  • GBIO $24,556,000.00
  • Revenue This Year
  • GAME $6.08
  • GBIO N/A
  • Revenue Next Year
  • GAME $21.94
  • GBIO N/A
  • P/E Ratio
  • GAME N/A
  • GBIO N/A
  • Revenue Growth
  • GAME 77.06
  • GBIO 146.47
  • 52 Week Low
  • GAME $0.50
  • GBIO $3.00
  • 52 Week High
  • GAME $2.87
  • GBIO $34.35
  • Technical
  • Relative Strength Index (RSI)
  • GAME 42.59
  • GBIO 54.72
  • Support Level
  • GAME $1.47
  • GBIO $4.05
  • Resistance Level
  • GAME $1.24
  • GBIO $5.10
  • Average True Range (ATR)
  • GAME 0.26
  • GBIO 0.63
  • MACD
  • GAME -0.10
  • GBIO 0.02
  • Stochastic Oscillator
  • GAME 0.02
  • GBIO 35.65

About GAME GameSquare Holdings Inc.

GameSquare Holdings Inc is engaged in revolutionizing the way brands and game publishers connect with hard-to-reach Gen Z, Gen Alpha, and Millennial audiences. It's next generation media, entertainment, and technology helps creators and maximize their brand partners' return on investment. Its purpose-built platform provides marketing and creative services, offers data and analytics solutions, and amplifies awareness through FaZe Clan.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: